Maruit Chulikavit, MPH

Articles by Maruit Chulikavit, MPH

Budget Impact of Everolimus in Treating Metastatic Renal Cell Carcinoma

ByMaria Lopes, MD,Maruit Chulikavit, MPH,Rohan Parikh, MS,Lee Stern, MS,Zhimei Liu, PhD,Jaqueline Rogerio, MD

November 13th 2012

A decision-analytical model shows that everolimus has a favorable budget impact when introduced into the treatment algorithm for metastatic renal cell carcinoma.

Latest Updated Articles

Budget Impact of Everolimus in Treating Metastatic Renal Cell Carcinoma
Published: November 13th 2012 | Updated:

Maruit Chulikavit, MPH

Articles by Maruit Chulikavit, MPH

Budget Impact of Everolimus in Treating Metastatic Renal Cell Carcinoma

Latest Updated Articles

Trending on Pharmacy Times

A Multifaceted Approach to Navigating Career Transitions in Pharmacy

Earlier Menopause, Reduced Cardiac Function Potentially Linked With Negative Impacts on Brain Health

Menopause Care Varies by Provider, Highlighting Need for Standardized Education